Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IL17RA | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | INPP5F | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
mRNA | SLC43A3 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
mRNA | FBXO7 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
mRNA | ATXN7L1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | MFSD12 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
mRNA | IFNGR2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | ERBB3 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
mRNA | PCDH1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | MYO15B | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |